Skip to main content
Log in

Inhibition of Metalloproteinase from Bitis arietans Venom In Vitro by the Ethyl Acetate Fraction of Moringa oleifera and Its Chemical Profile

  • Original Article
  • Published:
Revista Brasileira de Farmacognosia Aims and scope Submit manuscript

Abstract

Moringa oleifera Lam., Moringaceae, ethyl acetate soluble fraction has been documented to contain bioactive antivenom chemicals against Bitis arietans venom toxicities. Snake venom metalloproteinase is the principal enzyme of B. arietans venom exhibiting severe haemorrhage and haemostatic disturbances in envenomed victims. In this current study, B. arietans snake venom metalloproteinase was isolated using ion-exchange chromatography and gel filtration while SDS-PAGE was used to determine enzyme molecular weight. M. oleifera ethyl acetate soluble fraction was fractionated using column and thin-layer chromatography into subfractions and tested against B. arietans snake venom metalloproteinase. EchiTab polyvalent antivenom was used as the standard drug. The compounds present in the most active subfraction were identified using GCMS. The molecular weight of isolated enzyme was 43.28 kDa with specific activity of 3.06 μmol/min/mg and percentage yield of 18.5%. A total of 8 subfractions were obtained after fractionation and labelled ethyl acetate subfractions F1-8. All subfractions showed significant (p < 0.05) inhibition against B. arietans snake venom metalloproteinase activity. However, subfraction F5 demonstrated the highest inhibition against B. arietans snake venom metalloproteinase activity with total inhibition at all concentrations compared to other subfractions and antivenom. Subfraction F5 displayed substantial inhibition against the haemorrhagic, haemolytic, and anticoagulant activities of B. arietans venom with a dose-dependent effect. The major bioactive compounds of subfraction F5 were γ-sitosterol (5.92%), kaempferol (5.9%), quercetin (5.28%), n-hexadecanoic acid (5.23%), and n-pentacosane (5.22%) of which some were previously reported as potential snake venom inhibitors. Results showed that subfraction F5 possesses potential antivenom compounds that could be explored for snakebite treatment.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

Download references

Author information

Authors and Affiliations

Authors

Contributions

BSA conceptualized and designed the study under the guidance of AOA. BSA and FTB executed the antivenom experiments. PMO did the extract fractionation. BSA, JOO, and AA were responsible for drafting and reviewing the final manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Babafemi Siji Ajisebiola.

Ethics declarations

Ethical Approval

Animal experimental protocol in this study followed the guidelines of the University of Ibadan-Animal Care and Use Research Ethics Committee (UI-ACUREC) with approved number: UI-ACUREC/19/0030. The animal experimental procedures complied with the National Research Council’s publication on guide for the care and use of laboratory animals (National Research Council 2010).

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 453 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ajisebiola, B.S., Bello, F.T., Osamudiamen, P.M. et al. Inhibition of Metalloproteinase from Bitis arietans Venom In Vitro by the Ethyl Acetate Fraction of Moringa oleifera and Its Chemical Profile. Rev. Bras. Farmacogn. 33, 822–830 (2023). https://doi.org/10.1007/s43450-023-00416-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43450-023-00416-4

Keywords

Navigation